Kensuke Sakuma

<i>C. elegans</i> AMPKs promote survival and arrest germline development during nutrient stress

Masamitsu Fukuyama, Kensuke Sakuma, Riyong Park et al. · Biology Open · 2012 · 111 citations · Full text

Life Sciences, Biology, Developmental Biology +17

A Novel Antidiabetic Drug, Fasiglifam/TAK-875, Acts as an Ago-Allosteric Modulator of FFAR1

Chiori Yabuki, Hidetoshi Komatsu, Yoshiyuki Tsujihata et al. · PLoS ONE · 2013 · 92 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Anatomical Transcriptome of G Protein-Coupled Receptors Leads to the Identification of a Novel Therapeutic Candidate GPR52 for Psychiatric Disorders

Hidetoshi Komatsu, Minoru Maruyama, Yao Shuuhei et al. · PLoS ONE · 2014 · 76 citations · Full text

Life Sciences, Neuroscience, Pharmacology +17

FTBMT, a Novel and Selective GPR52 Agonist, Demonstrates Antipsychotic-Like and Procognitive Effects in Rodents, Revealing a Potential Therapeutic Agent for Schizophrenia

Keiji Nishiyama, Hirobumi Suzuki, Toshiya Harasawa et al. · Journal of Pharmacology and Experimental Therapeutics · 2017 · 37 citations

Medicine, Neuroscience, Pharmacology +14

Fasiglifam (TAK‐875) has dual potentiating mechanisms via G<i>α</i>q‐GPR40/FFAR1 signaling branches on glucose‐dependent insulin secretion

Kensuke Sakuma, Chiori Yabuki, Minoru Maruyama et al. · Pharmacology Research & Perspectives · 2016 · 28 citations · Full text

Life Sciences, Endocrinology, Pharmacology +17